Armistice Capital, LLC Belite Bio, Inc Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$32.33 - $50.1 $4.78 Million - $7.41 Million
148,000 New
148,000 $6.76 Million
Q4 2023

Feb 13, 2024
BUY
$29.5 - $46.02 $1.06 Million - $1.66 Million
36,000 New
36,000 $1.65 Million
Q2 2023

Aug 14, 2023
BUY
$11.18 - $30.2 $2.36 Million - $6.37 Million
210,915 New
210,915 $3.01 Million

Others Institutions Holding BLTE

# of Institutions
16
Shares Held
78.7K
Call Options Held
0
Put Options Held
0
View Full List

About BELITE BIO, INC

BLTE Quotes by TradingView
  • Ticker BLTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,867,400
  • Market Cap $2.06B
  • Description
  • Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...
More about BLTE
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email